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CONCISECOMMUNICATIONS

Absence of Kaposi's Sarcoma-Associated HerpesvirusDNA in Bacillary
Angiomatosis-Peliosis Lesions
David A. Relman,1-3 David N. Fredricks,12
Kristine E. Yoder,1AaGinat Mirowski,4-3
Timothy Berger,4 and Jane E. Koehler5

1Departmentof VeteransAffairs Palo Alto Health Care System,
Palo Alto, and Departments of2Medicine and 3Microbiology
and Immunology,Stanford University,Stanford, California;
Departments of *Dermatology and 5Medicine, University
of California, San Francisco

Bartonella henselae and B. quintana induce an unusual vascular proliferative tissue response
known as bacillary angiomatosis (BA) and bacillary peliosis (BP) in some human hosts. The
mechanisms of itorto/ie/fa-associated vascular proliferation remain unclear. Although host
factors probably play a role, microbial coinfection has not been ruled out. Because of the
vascular proliferative characteristics noted in both Kaposi's sarcoma (KS) and BA and occasional colocalization of KS and BA, the possibility was explored that KS-associated herpesvirus (KSHV) might be associated with BA lesions. Tissues with BA and positive and
negative control tissues were tested for the presence of KSHV DNA by a sensitive polymerase
chain reaction assay. Only 1 of 10 BA tissues, a splenic biopsy, was positive in this assay; this
tissue was from a patient with concomitant KS of the skin. Thus, KSHV is probably not
involved in the vascular proliferative response seen in BA-BP.

Vascular proliferation is characteristic of the local tissue response to several microbial pathogens, including Bartonellabacilliformis, B. henselae, and B. quintana. When immunocompromised persons are infected with the latter two species,
bacillary angiomatosis (BA) and bacillary peliosis (BP) may
develop [1, 2]. In contrast, immunocompetent persons rarely
develop BA-BP [3]; they more typically develop granulomatous
(cat-scratch disease) and bacteremic disease (trench fever) without angioproliferation during infection with B. henselae and B.
quintana, respectively [4].
At least four hypotheses explain the variable host response
to B. henselae and B. quintana. First, the state of immune competence determines whether host angioproliferative factors are
expressed locally; second, only certain Bartonella strains with
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angiogenic potential circulate among immunocompromised
persons; third, greater degrees of local Bartonella replication
occur in the face of host immunosuppression, resulting in
greater bacterial production of vascular proliferative factors;
and fourth, BA and BP occur only in the presence of a coinfecting agent with angiogenic properties [5].
The ability of one pathogen to modify the host response to
a coinfecting organism is an increasingly common theme [6].
Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is the
putative cause of KS, a disease characterized by vascular proliferation [7]. Many of the persons at greatest risk for BA and
BP are also infected with KSHV The local host cellular responses to KSHV might create a permissive or favorable environment for the formation of BA. The striking colocalization
of macroscopic KS and BA cutaneous lesions in several patients
(see case report below) also stimulated our interest in investigating this hypothesis. The question was whether KSHV could
be detected at the molecular level in lesions that appeared to
be BA without KS at the macroscopic level. Therefore, we
investigated the possible coassociation of Bartonella and KSHV
within the vascular proliferative lesions of BA, using assays
based upon the polymerase chain reaction (PCR).
Materials and Methods
Patients and tissue specimens. We studied 10 tissue specimens
with pathology typicalof eitherBA or BP (BA1-BA10) and 3 tissue
specimenswith pathology typical of KS (KS1-KS3) from 13 unrelatedpatients, along with control samples (C1-C8), in a blinded
fashion. Nine of the 10 BA-BP (herein referredto as "BA") specimens were skin lesions; all but 1 of these 9 patients were human
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Figure 1. A, Close-up view of representative cutaneous lesions reveals well-demarcated violaceous plaques. Within plaques are irregularly
arranged smooth, rounded red papules suggestive of bacillary angiomatosis/bacillary peliosis (BA). B, High-power view of superficial dermis from
cutaneous biopsy specimen (hematoxylin-eosin stain) reveals lobulated vessels lined by plump, cuboidal endothelial cells, consistent with BA.
Associated with superficial structures are amorphous clumps of lightly basophilic material. Warthin-Starry silver stain (insert) reveals aggregates
of bacillary organisms (arrows). C, High-power view of deep reticular dermis from cutaneous biopsy specimen shows spindled cells forming
irregular,slit-like vessels with extravasated red blood cells and hemosiderin, consistent with Kaposi's sarcoma.

immunodeficiency virus (HIV) seropositive. The HIV-seronegative

patientwith cutaneous BA was apparentlyimmunocompetentand
has been reported[3]. The tenth specimen(BA4) was spleen tissue
with BP from an HIV-seropositive person. All 3 KS specimens were
skin biopsies from HIV-seropositive patients. Eight coded "negative-control" samples were collected at the same institution as the
BA and KS specimens and included 1 skin sample from an HIVseronegative person (Cl), 1 spleen sample from an HIV-seropositive

person (C2), 2 spleen samplesfrom HIV-seronegativepersons(C3,
C5), liver (C4) and bone (C6) from HIV-seropositivepersons, a
water sample (C7), and tissue digestion buffer (C8). All of the
tissues listed were digested using a proceduredescribedelsewhere
[1] and then sent to one of the coauthors at a differentinstitution
for furtheranalysis.
PCR assays. A PCR assay for 16S rDNA from Bartonella
species and closely related a-proteobacteriawas performedwith
primers12Eand 24B as describedelsewhere[8].All digestedtissues
weretestedfor human0-globin gene sequenceswith primersGH20
and PC04 using established conditions [8]. KSHV open-reading
frame(ORF) 26 (minorcapsidgene) DNA (KS330233)
was detected
using two primers described by Chang et al. [7], KS-223F (5'AGCCGAAAGGATTCCACCAT-3')and KS-223R (5'-TCCGTThe KSHV ORF 26 assay was done
GTTGTCTACGTCCAG-3').

with the conditions described originally [7] as well as with the
of each
following modified conditions: 2 mM MgCl2, 200 C1M
dNTP, 800 nM of each primer, 1 U of Amplitaq gold (PerkinElmer, Norwalk, CT), a 50-CILfinal reaction volume, 94vCincubation for 10 min, followed by 50 cycles comprising 94iC for 30
s, 580C for 30 s, 720C for 30 s, and then a 7-min incubation at
72wC.The sensitivityof the KSHV assay was determinedusing the
modified set of conditions and serial dilutions of a plasmid containing a 600-bp fragment of ORF 26, which includes the two
primerannealingsites (gift of D. Kedes and D. Ganem, University
of California,San Francisco).In addition to controls C1-C8, negative controls includedreactionswith water and PCR reagents.All
reactions were set up and analyzed in two different rooms; since
BA, KS, and control specimenswere analyzed in a blinded, coded
fashion, positive and negative sampleswere randomlyinterspersed
during analysis.

Case Report
A 37-year-old homosexual man with AIDS and 104 CD4
cells/mm3was diagnosed with KS 2 years before admission. He
was undergoing treatment for cytomegalovirus (CMV) esoph-
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patient was treated with erythromycin but developed pleural
effusion, pneumothorax, and acute renal failure and died on
hospital day 17. An autopsy revealed disseminated BA, peliosis
hepatitis, and generalized KS. Colocalization of BA and KS
also occurred in the gastrointestinal tract and the lung. There
was no evidence of cholangitis.

Results

Figure 2. Agarosegel electrophoresisof DNA productsfromKaherpesvirus(KSHV)open-readingframe26
posi's sarcoma-associated
polymerasechain reactionassay (usingmodifiedexperimentalprotocol). By lane: 1, tissue BAl; 2, BA2; 3, BA3; 4, KS1; 5, KS2;6, Cl;
7, BA4, 8, water;9, digestionbuffer;10, water;11, 105targetcopies;
12, 102targetcopies;13, 5 targetcopies;14, 1 targetcopy.At rightof
each panelis 100-bpDNA ladder(200- and 300-bpbandsindicated).
Expectedsize of productfromKSHVgenomeis 233 bp. BA, bacillary
angiomatosis.

agitis and retinitis and diffuse cutaneous KS and was transfusion dependent. Three weeks before admission, he completed
two cycles of bleomycin and vincristine. Subsequently, he developed daily fevers to 380C and epigastric and right upper
quadrant abdominal pain and was admitted for evaluation of
CMV cholangitis. On admission, his temperature was 390C.
Physical examination revealed an enlarged liver and palpable
spleen tip. Cutaneous findings included extensive, well-demarcated, violaceous cutaneous plaques. Localized and limited to
and within these plaques were irregularly arranged smooth,
rounded red papules and nodules, whose appearance was suspicious for BA (figure lA). Skin biopsy specimens were obtained for histopathology and culture before initiation of antibiotics. The histopathologic findings revealed both KS and
BA. In the superficial dermis (figure IB), lobulated vascular
structures lined by plump, cuboidal endothelial cells were
found. Associated with the superficial vascular structures were
amorphous clumps of lightly basophilic material, which were
clumps of bacillary organisms on Warthin-Starrysilver staining
(figure IB insert), consistent with BA. In contrast, in the deep
reticular dermis (figure 1C), spindled cells formed irregularslitlike structures with extravasated red blood cells and hemosiderin consistent with KS.
B. henselae was isolated from the blood and from the cutaneous BA-KS lesion. On further questioning, the patient recalled having received a serious cat scratch 3 years earlier. The

Confirmationof diagnosis in BA and KS tissues. All 10 BA
tissue digests yielded products of the expected size (296 bp) with
the Bartonella range-restricted PCR assay, while none of the
KS digests or controls generated any visible product (data not
shown). Bartonella species (either B. henselae or B. quintana)
were cultivated from some, and Bartonella species 16S rDNA
was detected by amplification and DNA sequencing in all of
the same BA specimens in previous experiments in a different
laboratory [2]. A DNA product of the expected size (233 bp)
was amplified from all 3 KS specimen digests by use of the
KSHV PCR assay with both experimental protocols (see figure
2, lanes 4 and 5) and not from any digest buffer or PCR reagentonly controls (figure 2, lanes 8-10). By use of serial dilutions
of cloned ORF 26 template DNA, the sensitivity of the KSHV
PCR assay with the modified protocol was estimated to be 5
template copies (see figure 2, lanes 11-14).
All but 1 of the 19 tissue digests yielded an amplified product
of the expected size using human 0-globin gene primers on
repeated testing over a 2-year period (data not shown); the
exception (Cl) was positive for 0-globin DNA at the time of
initial Bartonella and KSHV PCR testing; however, it was negative in the 0-globin PCR assay 2 years later, when the modified
KSHV assay was performed. These results provide evidence
that all of the BA and KS tissues were infected with Bartonella
species or KSHV, respectively, as one would have predicted,
and that the tissue digests all contained amplifiable DNA.
Assessment of KSHV infection in BA and control tissues.
No evidence of KSHV DNA was found in 9 of the 10 BA
specimens. From specimen BA4, a product of the expected size
was detected using the modified KSHV PCR assay (figure 2,
lane 7). BA4 was a spleen sample with typical BP histology
from an HIV-seropositive patient who had biopsy-proven cutaneous KS. Four of the 6 tissue controls with normal histology
were negative in this KSHV PCR assay (C1, C3, C5, C6); tissues
C2 and C4 were positive despite the absence of any pathology.
C2 was splenic tissue from an HIV-seropositive person with
intra-abdominal lymphatic KS. This result and that from BA4
might be explained by the known ability of KSHV to disseminate within the host well beyond sites of typical KS pathology
[7, 9]. The other control tissue that yielded an unexpected positive result in the KSHV assay was a liver specimen (C4) with
no evidence of KS from an HIV-seropositive person with angioimmunoblastic lymphadenopathy (AILD). In one study,
KSHV DNA was detected in 3 of 15 tissue specimens with this
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disease[10].Whileour findingsin thiscase
lymphoproliferative
and this studyraiseinterestingquestionsaboutthepossiblerole
of this virusin AILD, we cannot excludea noncausalassociation in a host at elevatedrisk for KSHV acquisition.

Discussion
KSHV has been associatedwith body cavity-basedlymphoma,multicentricCastleman'sdisease,AILD, and KS. This
virus encodeshomologuesof chemokine-likeproteinsvMIP-I
and vMIP-II,whichare angiogenicin vitro [11].Ourcase and
other similarcases have drawnattentionover the past decade
to the possiblyfrequentcoassociationof KSHVand Bartonella
speciesin BA lesionsanda possiblerolefor KSHVas a cofactor
in the vascularproliferationof BA-BP.However,the resultsof
our study argueagainstthese possibilities.Our data indicate
that if KSHV is found in BA lesions,it occursinfrequentlyor
in extremelylow numbers.These data suggestthat KSHV is
unlikelyto be a cofactorin the vascularproliferationassociated
with BA bacilliand suggestthat researcheffortsbe focusedon
other possibilities.Whilethe vascularproliferationin BA and
BP may involve host induction or bacterialproductionof
growthfactorsand cytokinesthat promotenew vesselformation [12],the exactmechanismsof this fascinatingand unusual
host responseto infectionremainto be elucidated.
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